Czech Republic: mRNA vaccine for skin cancer reduces recurrence risk by nearly half
A new mRNA vaccine tested by pharmaceutical companies Merck and Moderna significantly lowers the risk of melanoma returning after surgery. This treatment offers a more effective preventative option than previous standard therapies for skin cancer patients.